Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic significance of cyclin D1 polymorphisms on prostate-specific antigen recurrence after radical prostatectomy.

Annals of surgical oncology - 1 Dec 2013

Yu Chia-Cheng, Lin Victor C, Huang Chao-Yuan, Liu Chia-Chu, Wang Jyh-Seng, Wu Tony T, Pu Yeong-Shiau, Huang Chun-Hsiung, Huang Chun-Nung, Huang Shu-Pin, Bao Bo-Ying

Abstract excerpt

BACKGROUND: Cyclin D1 (CCND1) is an important cell-cycle regulator involved in carcinogenesis and progression of prostate cancer. We tested whether genetic variations within the CCND1 gene are related to clinical outcomes in prostate cancer patients receiving radical prostatectomy. METHODS: A tot...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cyclin D1
Share to Follow-Up Studies
Share to Neoplasm Grading

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Recurrence, Local

Share to Neoplasm Staging

Share to Prostate-Specific Antigen

Share to Prostatectomy

Share to Prostatic Neoplasms

Source

Identifiers

PMID: 23354566
DOI: 10.1245/s10434-013-2869-x

Genes

CCND1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23354566-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic significance of cyclin D1 polymorphisms on prostate-specific antigen recurrence after radical prostatectomy.PMID 23354566Read ↗

Prognostic significance of prostate cancer susceptibility variants on prostate-specific antigen recurrence after radical prostatectomy.Semantic proximity Read ↗

Genome-wide detection of allelic genetic variation to predict biochemical recurrence after radical prostatectomy among prostate cancer patients using an exome SNP chip.Semantic proximity Read ↗

The cyclin D1 (CCND1) rs9344 G>A polymorphism predicts clinical outcome in colon cancer patients treated with adjuvant 5-FU-based chemotherapy.Semantic proximity Read ↗

Comparative analysis of genetic risk scores for predicting biochemical recurrence in prostate cancer patients after radical prostatectomy.Semantic proximity Read ↗

Improved prediction of biochemical recurrence after radical prostatectomy by genetic polymorphisms.Semantic proximity Read ↗

Cyclin D1 gene polymorphism and familial prostate cancer: the AA genotype of A870G polymorphism is associated with prostate cancer risk in men aged 70 years or older and metastatic stage.Semantic proximity Read ↗

SNP rs1059234 in CDKN1A Gene Correlates with Prognosis in Resected Gastric Adenocarcinoma.Semantic proximity Read ↗

Genetic predisposition to early recurrence in clinically localized prostate cancer.Semantic proximity Read ↗

Genetic polymorphisms in cyclin D1 are associated with risk of renal cell cancer in the Chinese populationSemantic proximity Read ↗

CCND1 rs9344 polymorphisms are associated with the genetic susceptibility to cervical cancer in Chinese population.Semantic proximity Read ↗

Prognostic Value of Prostaglandin-endoperoxide Synthase 2 Polymorphisms in Prostate Cancer Recurrence after Radical Prostatectomy.Semantic proximity Read ↗

Prognostic Value of CD1B in Localised Prostate Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.